Clinical Trials
- Thyroid and Other Endocrine Cancers, Pancreatic Cancer
Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors
EndoGene
- Pancreatic Cancer
Phase II Randomized, Prospective Trial of Lutetium Lu 177 Dotatate PRRT Versus Capecitabine and Temozolomide in Well-Differentiated Pancreatic Neuroendocrine Tumors
- Prostate Cancer, Bladder Cancer
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
- Endocrine System
Sight-saving Engagement and Evaluation in New Haven (SEEN) Program
- Genetics, Mental Health & Behavioral Research
EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway
- Ages6 years - 65 years
- GenderBoth
- Thyroid and Other Endocrine Cancers, Gynecological Cancers
Endometrium and Metabolism
- Brain, Spinal Cord & Nervous System
Imaging pancreatic beta-cells with PET neuroimaging agent 11C-PHNO
- Ages18 years - 65 years
- GenderBoth
- Mental Health & Behavioral Research
ProNET